Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

被引:281
作者
Hoste, Levi [1 ,2 ]
Van Paemel, Ruben [3 ,4 ,5 ]
Haerynck, Filomeen [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Pulmonol Infect Dis & Immunol, Ghent, Belgium
[2] Ghent Univ Hosp, Primary Immunodeficiency Res Lab, Ctr Primary Immunodeficiency Ghent, Jeffrey Modell Diag & Res Ctr, Ghent, Belgium
[3] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[4] Canc Res Inst Ghent CRIG, Ghent, Belgium
[5] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium
关键词
PIMS-TS; MIS-C; COVID-19; SARS-CoV-2; MIMICKING KAWASAKI-DISEASE; SARS-COV-2; PIMS-TS; MIS-C; INVOLVEMENT; SHOCK; INFECTION; DIAGNOSIS;
D O I
10.1007/s00431-021-03993-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases. Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial. What is Known: A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis. What is New: This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.
引用
收藏
页码:2019 / 2034
页数:16
相关论文
共 50 条
  • [1] Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
    Levi Hoste
    Ruben Van Paemel
    Filomeen Haerynck
    European Journal of Pediatrics, 2021, 180 : 2019 - 2034
  • [2] COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis
    Yasuhara, Jun
    Watanabe, Kae
    Takagi, Hisato
    Sumitomo, Naokata
    Kuno, Toshiki
    PEDIATRIC PULMONOLOGY, 2021, 56 (05) : 837 - 848
  • [3] Multisystem inflammatory syndrome in children with COVID-19
    Gottlieb, Michael
    Bridwell, Rachel
    Ravera, Joseph
    Long, Brit
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 49 : 148 - 152
  • [4] Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19
    Veraldi, Noemi
    Vives, Romain R.
    Blanchard-Rohner, Geraldine
    L'Huillier, Arnaud G.
    Wagner, Noemie
    Rohr, Marie
    Beghetti, Maurice
    De Agostini, Ariane
    Grazioli, Serge
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2022, 100 (05): : 735 - 746
  • [5] Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Infection: A Comprehensive Review
    Meza-Contreras, Alejandra Isabel
    Galdos-Bejar, Marcelo Nicolas
    Escalante-Kanashiro, Raffo
    JOURNAL OF PEDIATRIC INTENSIVE CARE, 2022,
  • [6] Echocardiographic Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review
    Karimi, Amirali
    Ghafouri, Parham
    Alilou, Sanam
    Rezaei, Nima
    Talesh, Shaghayegh Ashraf
    Ashraf, Haleh
    IRANIAN JOURNAL OF PEDIATRICS, 2022, 32 (02)
  • [7] Clinical Presentation and Management of Multisystem Inflammatory Syndrome in Children With COVID-19: A Systematic Review
    Albanji, Mohammed H.
    Baghafar, Ahmed A.
    Alghanmi, Yasser A.
    Shaaban, Mohammed M.
    Alkashlan, Ebrahim A.
    Sende, Haifa H.
    Alzahrani, Mofareh S.
    Filfilan, Nuha N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [8] Vitamin D and morbidity in children with Multisystem inflammatory syndrome related to Covid-19
    Rivera, Diana Torpoco
    Misra, Amrit
    Sanil, Yamuna
    Sabzghabaei, Natalie
    Safa, Raya
    Garcia, Richard U.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2022, 66
  • [9] COVID-19 and multisystem inflammatory syndrome in children
    Lara Alvarez, Adriana Paola
    Salamea Urdiales, Andrea Carolina
    Chacon Velez, Ivan Paul
    Pacheco Melan, Benjamin
    Ardila Carreno, Maria Alejandra
    Guerrero Fajardo, Israel
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2021, 16 (02): : 168 - +
  • [10] Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19
    Long, Fangyuan
    Zhu, Shiheng
    Wang, Zeguang
    Zhang, Shungeng
    He, Jinlong
    Ge, Xinbin
    Ning, Jun
    FUTURE VIROLOGY, 2023, 18 (01) : 63 - 74